{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:36:09Z","timestamp":1791894969838,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Percutaneous cryoablation (PCA), having shown effectiveness in treating liver, lung, prostate, breast, and kidney tumors, is now gaining attention for the treatment of soft tissue tumors. PCA functions by freezing tissue, which induces ice crystal formation and cell death without damaging collagen structures. Technical considerations include the selection and handling of cryoprobes and cryogenic agents, procedural duration, and choice of image guidance for precision. This review aims to synthesize the mechanisms, applications, and technical aspects of PCA in the treatment of soft tissue tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adhering to PRISMA 2020 guidelines, a review was conducted of studies published prior to March 2024 that investigated PCA of soft tissue tumors. The review focused on technical and procedural aspects of cryoablation, cryobiological principles, cellular and tissue responses to extreme cold, intra- and post-procedure physiological mechanisms during and post-procedure, and main clinical applications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PCA is efficient in treating soft tissue tumors, including desmoid tumors, vascular malformations, and abdominal wall endometriosis. Several cryobiological mechanisms are involved, notably ice crystal formation, cellular dehydration, osmotic effects, and the inflammatory response, all of which contribute to its efficacy. Key technical aspects include the choice of cryoprobes, cryogenic agents (argon gas or liquid nitrogen), and the duration and control of freezing\/thawing cycles. PCA also frequently outperformed traditional treatments like surgery and radiotherapy in terms of pain reduction, tumor size reduction, and patient outcomes. Moreover, its nerve sideration properties make it effective under local anesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Demonstrating substantial pain reduction, tumor size decrease, and high technical success rates, PCA offers a promising and minimally invasive alternative for soft tissue tumor treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Percutaneous cryoablation provides a minimally invasive, precise alternative for soft tissue tumor management, advancing clinical radiology by offering effective treatment with reduced patient risk and enhanced outcomes through image-guided procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Percutaneous cryoablation (PCA) offers a promising, minimally invasive alternative for managing soft tissue tumors.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>PCA employs image-guided techniques to accurately target and treat tumors, ensuring high precision and control.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>PCA preserves structures like collagen, reduces pain, decreases tumor size, and generally enhances patient outcomes.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-024-01822-5","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T10:08:49Z","timestamp":1731924529000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Percutaneous cryoablation in soft tissue tumor management: an educational review"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-3361","authenticated-orcid":false,"given":"Sylvain","family":"Bodard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Geevarghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Razakamanantsoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Frandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Marcelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1058-0884","authenticated-orcid":false,"given":"Fran\u00e7ois H.","family":"Cornelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.soc.2016.05.001","volume":"25","author":"VY Jo","year":"2016","unstructured":"Jo VY, Doyle LA (2016) Refinements in sarcoma classification in the current 2013 World Health Organization classification of tumours of soft tissue and bone. Surg Oncol Clin North Am 25:621\u2013643. https:\/\/doi.org\/10.1016\/j.soc.2016.05.001","journal-title":"Surg Oncol Clin North Am"},{"key":"1822_CR2","doi-asserted-by":"publisher","unstructured":"Bodard S, Marcelin C, Kastler A et al (2024) Safety and efficacy of cryoablation of soft-tissue tumors. Br J Radiol 2024:tqae075. https:\/\/doi.org\/10.1093\/bjr\/tqae075","DOI":"10.1093\/bjr\/tqae075"},{"key":"1822_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3892\/or.2014.3378","volume":"32","author":"N Oebisu","year":"2014","unstructured":"Oebisu N, Hoshi M, Ieguchi M et al (2014) Contrast-enhanced color Doppler ultrasonography increases diagnostic accuracy for soft tissue tumors. Oncol Rep 32:1654\u20131660. https:\/\/doi.org\/10.3892\/or.2014.3378","journal-title":"Oncol Rep"},{"key":"1822_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10300-4","volume":"22","author":"S Bodard","year":"2022","unstructured":"Bodard S, Lassalle L, Larousserie F et al (2022) Performance of sonoelastography for predicting malignancy in soft tissue. BMC Cancer 22:1305. https:\/\/doi.org\/10.1186\/s12885-022-10300-4","journal-title":"BMC Cancer"},{"key":"1822_CR5","doi-asserted-by":"publisher","unstructured":"Geevarghese R, Bodard S, Razakamanantsoa L et al (2024) Interventional oncology: 2024 update. Can Assoc Radiol J 75:658\u2013670. https:\/\/doi.org\/10.1177\/08465371241236152","DOI":"10.1177\/08465371241236152"},{"key":"1822_CR6","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1055\/a-0598-5134","volume":"190","author":"AH Mahnken","year":"2018","unstructured":"Mahnken AH, K\u00f6nig AM, Figiel JH (2018) Current technique and application of percutaneous cryotherapy. Rofo 190:836\u2013846. https:\/\/doi.org\/10.1055\/a-0598-5134","journal-title":"Rofo"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/1522-2586(200101)13:1<99::AID-JMRI1015>3.0.CO;2-O","volume":"13","author":"K Butts","year":"2001","unstructured":"Butts K, Sinclair J, Daniel BL, Wansapura J, Pauly JM (2001) Temperature quantitation and mapping of frozen tissue. J Magn Reson Imaging 13:99\u2013104. https:\/\/doi.org\/10.1002\/1522-2586(200101)13:1<99::AID-JMRI1015>3.0.CO;2-O","journal-title":"J Magn Reson Imaging"},{"key":"1822_CR8","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.jvir.2009.12.403","volume":"21","author":"JP Erinjeri","year":"2010","unstructured":"Erinjeri JP, Clark TWI (2010) Cryoablation: mechanism of action and devices. J Vasc Interv Radiol 21:S187\u2013S191. https:\/\/doi.org\/10.1016\/j.jvir.2009.12.403","journal-title":"J Vasc Interv Radiol"},{"key":"1822_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.diii.2013.02.001","volume":"94","author":"F Cornelis","year":"2013","unstructured":"Cornelis F, Havez M, Lippa N et al (2013) Radiologically guided percutaneous cryotherapy for soft tissue tumours: a promising treatment. Diagn Interv Imaging 94:364\u2013370. https:\/\/doi.org\/10.1016\/j.diii.2013.02.001","journal-title":"Diagn Interv Imaging"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/bjsm.2006.031237","volume":"41","author":"AA Algafly","year":"2007","unstructured":"Algafly AA, George KP (2007) The effect of cryotherapy on nerve conduction velocity, pain threshold and pain tolerance. Br J Sports Med 41:365\u2013369. https:\/\/doi.org\/10.1136\/bjsm.2006.031237","journal-title":"Br J Sports Med"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"1094009","DOI":"10.3389\/fimmu.2023.1094009","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Meng L, Zhang J, Zhang X (2023) Progress in the cryoablation and cryoimmunotherapy for tumor. Front Immunol 14:1094009. https:\/\/doi.org\/10.3389\/fimmu.2023.1094009","journal-title":"Front Immunol"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"e1049802","DOI":"10.1080\/2162402X.2015.1049802","volume":"5","author":"D Chandra","year":"2016","unstructured":"Chandra D, Jahangir A, Cornelis F et al (2016) Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer. Oncoimmunology 5:e1049802. https:\/\/doi.org\/10.1080\/2162402X.2015.1049802","journal-title":"Oncoimmunology"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1089\/end.2009.0587","volume":"24","author":"PC Sprenkle","year":"2010","unstructured":"Sprenkle PC, Mirabile G, Durak E et al (2010) The effect of argon gas pressure on ice ball size and rate of formation. J Endourol 24:1503\u20131507. https:\/\/doi.org\/10.1089\/end.2009.0587","journal-title":"J Endourol"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jhep.2016.09.003","volume":"66","author":"SJ Ahn","year":"2017","unstructured":"Ahn SJ, Lee JM, Lee DH et al (2017) Real-time US-CT\/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol 66:347\u2013354. https:\/\/doi.org\/10.1016\/j.jhep.2016.09.003","journal-title":"J Hepatol"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1148\/radiol.2018172743","volume":"288","author":"KD Song","year":"2018","unstructured":"Song KD, Lee MW, Rhim H et al (2018) Percutaneous US\/MRI fusion-guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes. Radiology 288:878\u2013886. https:\/\/doi.org\/10.1148\/radiol.2018172743","journal-title":"Radiology"},{"key":"1822_CR16","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1007\/s00330-021-07930-w","volume":"31","author":"L Monfardini","year":"2021","unstructured":"Monfardini L, Gennaro N, Orsi F et al (2021) Real-time US\/cone-beam CT fusion imaging for percutaneous ablation of small renal tumours: a technical note. Eur Radiol 31:7523\u20137528. https:\/\/doi.org\/10.1007\/s00330-021-07930-w","journal-title":"Eur Radiol"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1055\/a-1021-1616","volume":"42","author":"E Xu","year":"2021","unstructured":"Xu E, Li K, Long Y et al (2021) Intra-procedural CT\/MR-ultrasound fusion imaging helps to improve outcomes of thermal ablation for hepatocellular carcinoma: results in 502 nodules. Ultraschall Med 42:e9\u2013e19. https:\/\/doi.org\/10.1055\/a-1021-1616","journal-title":"Ultraschall Med"},{"key":"1822_CR18","doi-asserted-by":"publisher","unstructured":"Weimar T, Lee AM, Ray S, Schuessler RB, Damiano RJ (2012) Evaluation of a novel cryoablation system: in vitro testing of heat capacity and freezing temperatures. Innovations 7:403\u2013409. https:\/\/doi.org\/10.1177\/155698451200700606","DOI":"10.1177\/155698451200700606"},{"key":"1822_CR19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/RLI.0000000000000642","volume":"55","author":"J Tokuda","year":"2020","unstructured":"Tokuda J, Wang Q, Tuncali K, Seethamraju RT, Tempany CM, Schmidt EJ (2020) Temperature-sensitive frozen-tissue imaging for cryoablation monitoring using STIR-UTE MRI. Invest Radiol 55:310\u2013317. https:\/\/doi.org\/10.1097\/RLI.0000000000000642","journal-title":"Invest Radiol"},{"key":"1822_CR20","doi-asserted-by":"publisher","first-page":"20230620","DOI":"10.1259\/bjr.20230620","volume":"96","author":"S Bodard","year":"2023","unstructured":"Bodard S, Guinebert S, Petre EN et al (2023) Percutaneous liver interventions with robotic systems: a systematic review of available clinical solutions. Br J Radiol 96:20230620. https:\/\/doi.org\/10.1259\/bjr.20230620","journal-title":"Br J Radiol"},{"key":"1822_CR21","doi-asserted-by":"publisher","first-page":"00392","DOI":"10.1016\/j.bulcan.2022.09.011","volume":"S0007-4551","author":"S Bodard","year":"2022","unstructured":"Bodard S, Kharroubi-Lakouas D, Guinebert S et al (2022) [Cancer imaging and prevention of renal failure]. Bull Cancer S0007-4551:00392\u201300397. https:\/\/doi.org\/10.1016\/j.bulcan.2022.09.011","journal-title":"Bull Cancer"},{"key":"1822_CR22","doi-asserted-by":"publisher","unstructured":"Grand T, Delavaud C, Dariane C et al (2023) Contrast enhancement early after renal malignancy cryoablation: imaging findings associated with benignity. Eur Radiol 33:8703\u20138714. https:\/\/doi.org\/10.1007\/s00330-023-09814-7","DOI":"10.1007\/s00330-023-09814-7"},{"key":"1822_CR23","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00270-022-03247-3","volume":"45","author":"V Duteau","year":"2022","unstructured":"Duteau V, Espitia O, Perret C et al (2022) Cryoablation of soft tissues low-flow vascular malformations: clinical outcomes and safety. Cardiovasc Intervent Radiol 45:1784\u20131792. https:\/\/doi.org\/10.1007\/s00270-022-03247-3","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1822_CR24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jvsv.2022.08.004","volume":"11","author":"J Cao","year":"2023","unstructured":"Cao J, Liu J, Zhang X, Wang Z (2023) A systematic review and network meta-analysis of the effectiveness of sclerotherapy for venous malformation. J Vasc Surg Venous Lymphat Disord 11:210\u2013218.e3. https:\/\/doi.org\/10.1016\/j.jvsv.2022.08.004","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"1822_CR25","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.diii.2014.02.008","volume":"95","author":"N Lippa","year":"2014","unstructured":"Lippa N, Sargos P, Italiano A et al (2014) Standardization of selection criteria for percutaneous image-guided cryoablation of recurrent soft-tissue sarcomas. Diagn Interv Imaging 95:1071\u20131077. https:\/\/doi.org\/10.1016\/j.diii.2014.02.008","journal-title":"Diagn Interv Imaging"},{"key":"1822_CR26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ogc.2022.02.013","volume":"49","author":"CE Foley","year":"2022","unstructured":"Foley CE, Ayers PG, Lee TT (2022) Abdominal wall endometriosis. Obstet Gynecol Clin North Am 49:369\u2013380. https:\/\/doi.org\/10.1016\/j.ogc.2022.02.013","journal-title":"Obstet Gynecol Clin North Am"},{"key":"1822_CR27","doi-asserted-by":"publisher","first-page":"363.e1","DOI":"10.1016\/j.ajog.2014.04.011","volume":"211","author":"AM Ecker","year":"2014","unstructured":"Ecker AM, Donnellan NM, Shepherd JP, Lee TTM (2014) Abdominal wall endometriosis: 12 years of experience at a large academic institution. Am J Obstet Gynecol 211:363.e1\u20135. https:\/\/doi.org\/10.1016\/j.ajog.2014.04.011","journal-title":"Am J Obstet Gynecol"},{"key":"1822_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jmig.2019.10.004","volume":"27","author":"MP Andres","year":"2020","unstructured":"Andres MP, Arcoverde FVL, Souza CCC, Fernandes LFC, Abr\u00e3o MS, Kho RM (2020) Extrapelvic endometriosis: a systematic review. J Minim Invasive Gynecol 27:373\u2013389. https:\/\/doi.org\/10.1016\/j.jmig.2019.10.004","journal-title":"J Minim Invasive Gynecol"},{"key":"1822_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00595-012-0459-3","volume":"44","author":"M Mistrangelo","year":"2014","unstructured":"Mistrangelo M, Gilbo N, Cassoni P et al (2014) Surgical scar endometriosis. Surg Today 44:767\u2013772. https:\/\/doi.org\/10.1007\/s00595-012-0459-3","journal-title":"Surg Today"},{"key":"1822_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ygyno.2020.12.037","volume":"160","author":"MR Moynagh","year":"2021","unstructured":"Moynagh MR, Dowdy SC, Welch B et al (2021) Image-guided tumor ablation in gynecologic oncology: review of interventional oncology techniques and case examples highlighting a collaborative, multidisciplinary program. Gynecol Oncol 160:835\u2013843. https:\/\/doi.org\/10.1016\/j.ygyno.2020.12.037","journal-title":"Gynecol Oncol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-024-01822-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-024-01822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T11:02:49Z","timestamp":1731927769000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-024-01822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s13244-024-01822-5","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"F.H.C. is a Boston Scientific, Varian, and IceCure consultant. The remaining authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}